Dynavax Technologies Corporation

(DVAX) Trade

By |

Profile

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor ("TLR") stimulation.

Contact Information

Website: www.dynavax.com
Email: contact@dynavax.com
Main Phone: +1 510 848-5100
Address: 2929 Seventh Street
Address 2: Suite 100
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710-2753

Issuer Information

Exchange: NSC
CEO: Eddie Gray
Employees: 192
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 12.20 $ 0.25 (2.09%)
Last Price 12.20 Change $ 0.25 Change % 2.09 Tick N/A
Bid 11.80 Bid Size 500.00 Ask 12.15 Ask Size 200.00
Open 12.05 High 12.25 Low 11.75 Prev Close 11.95
Last Trade Volume 493,265 52 Wk Hi 24.45 52 Wk Low 11.35
Market Cap 763.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 62,615,586.00 EPS (TTM) -2.09 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 14 63
Number of Buys 6 29
Number of Sells 8 34
Net Activity 121174 407284
Last 10 Buys Shares
Robert Janssen 1,000
Robert Janssen 1,000
Eddie Gray 1,000
Eddie Gray 1,000
Robert Janssen 1,000
Robert Janssen 1,000
Eddie Gray 1,000
Peggy V. Phillips 1,000
Arnold L. Oronsky 1,000
Daniel L. Kisner 1,000
Last 10 Sell Shares
Michael S. Ostrach 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Johnson 1,000
Robert L. Coffman 1,000
Robert L. Coffman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 27 27 27 27
Mean Target Price Estimate 28 28 28 28
Standard Deviation 1.41 1.41 1.41 1.41
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 3
Moderate Buy 1 1 1 1
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.2 1.6 1.6